Understanding quality of life in patients with colorectal cancer: Comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population

Inflammation Research

Volumn 53, Issue SUPPL. 2, 2004, Pages

  Kopp, I ^a   Bauhofer, A ^a   Koller, M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Colorectal cancer; Outcomes research; Quality of life; Randomised controlled trial

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DATA ANALYSIS; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SOCIAL STATUS;

EID: 4344641115     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-0361-6     Document Type: Article

References (24)

1. Lorenz W, Troidl H, Solomkin JS, Nies C, Sitter H, Koller M et al. Second step: Testing - Outcome measurements. World J Surg 1999; 23: 768-80.
2. Koller M, Lorenz W. Quality of life: a deconstruction for clinicians. J R Soc Med 2002; 95: 481-8.
3. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
4. Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual, 3rd ed. 3 ed. Brussels: EORTC Study Group on Quality of Life, 2001.
5. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-51.
6. Conroy T, Bleiberg H, Glimelius B. Quality of life in patients with advanced colorectal cancer: what has been learnt? Eur J Cancer 2003; 39: 287-94.
7. Beaton DE. Simple as possible? Or too simple? Med Care 2003; 41(5): 593-6.
8. Bauhofer A, Lorenz W, Stinner B, Rothmund M, Koller M, Sitter H et al. Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by concensus of an international study group. Part two: design of the study. Inflamm Res 2001; 50: 187-205.
9. Feinstein AR. Clinical epidemiology. The architecture of clinical research. Philadelphia: Saunders, 1985.
10. Kopp I, Lorenz W, Rothmund M, Koller M. Relation between severe illness and non-completion of quality-of-life questionnaires by patients with rectal cancer. J R Soc Med 2003; 96(9):442-8.
11. Wennberg JE, Gittelsohn AM. Small area variations in health care delivery. Science 1973; 182: 1102-8.
12. Kopp I, Koller M, Stinner B, Hainbach S, Rothmund M, Lorenz W et al. Chirurgische Therapie des Rektumkarzinoms: Abbildung der realen Versorgungssituation im Rahmen einei kreisbezogenen Qualitätssicherungs- Studie. Chirurg 2001; 72: 1467-77.
13. Hermanek P. Qualitätsmanagement bei Diagnose und Therapie kolorektaler Karzinome. Leber Magen Darm 1996; 26: 20-4.
14. Eigler FW, Gabbert H, Herfarth C, Hermanek P, Hohenberger W, Hossfeld DK et al. Leitlinien zur Therapie des Rektumkarzinoms. Forum DKG 1997; 12: 292-7.
15. Lorenz W, Stinner B, Bauhofer A, Rothmund M, Celik I, Fingerhut A et al. Granulocyte-colony stimuiating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part one: rationale and hypothesis. Inflamm Res 2001; 50: 115-22.
16. Stinner B, Bauhofer A, Lorenz W, Rothmund M, Plaul U, Torossian A et al. Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical trial developed by consensus of an international study group. Part three: individual patient, complication algorithm and quality management. Inflamm Res 2001.
17. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-44.
18. Graf W, Ekström K, Glimelius B, Pahlman L. A pilot study of factors influencing bowel function after colorectal anastomosis. Dis Colon Rectum 1996; 39(7): 744-9.
19. Maurer CA, Z'graggen K, Renzulli P, Schilling MK, Netzer P, Büchler MW. Total mesorectal excision preservers male genital function compared with conventional rectal cancer surgery. Br J Surg 2001; 88: 1501-5.
20. Curran D, Bacchi M, Schmitz SF, Molenberghs G, Sylvester RJ. Identifying the types of missingness in quality of life data from clinical trials. Stat Med 1998; 17: 739-56.
21. Fairclough DL. Summary Measures and Statistics for Comparison of Quality of Life in a Clinical Trial of Cancer Therapy. Stat Med 1997; 16: 1197-209.
22. Kaasa S, Jensen Hjermstad M, Jordhoy MS, Wisloff F, Loge JH. Compliance in quality of life data: a norwegian experience. Stat Med 1998; 17: 623-32.
23. Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 1998; 317: 1191-4.
24. Hoppe de Mamani S, Schlag P. Lebensqualität nach Rektumchirurgie [Quality of life after rectal surgery]. Chirurg 2004; 75: 26-31.